Literature DB >> 26405289

Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data.

Marianne Paesmans1, Camilo Garcia2, Ching-Yee Oliver Wong3, Edward F Patz4, Ritsuko Komaki5, Susanne Eschmann6, Ramaswamy Govindan7, Johan Vansteenkiste8, Anne-Pascale Meert9, Wouter K de Jong10, Nasser Khaled Altorki11, Kotaro Higashi12, Angela Van Baardwijk13, Gerben R Borst14, Lieveke Ameye15, Jean-Jacques Lafitte16, Thierry Berghmans9, Patrick Flamen17, Ramon Rami-Porta18, Jean-Paul Sculier9.   

Abstract

(18)F-fluoro-2-deoxy-d-glucose positron emission tomography (PET) complements conventional imaging for diagnosing and staging lung cancer. Two literature-based meta-analyses suggest that maximum standardised uptake value (SUVmax) on PET has univariate prognostic value in nonsmall cell lung cancer (NSCLC). We analysed individual data pooled from 12 studies to assess the independent prognostic value of binary SUVmax for overall survival.After searching the published literature and identifying unpublished data, study coordinators were contacted and requested to provide data on individual patients. Cox regression models stratified for study were used.Data were collected for 1526 patients (median age 64 years, 60% male, 34% squamous cell carcinoma, 47% adenocarcinoma, 58% stage I-II). The combined univariate hazard ratio for SUVmax was 1.43 (95% CI 1.22-1.66) and nearly identical if the SUV threshold was calculated stratifying for histology. Multivariate analysis of patients with stage I-III disease identified age, stage, tumour size and receipt of surgery as independent prognostic factors; adding SUV (HR 1.58, 95% CI 1.27-1.96) improved the model significantly. The only detected interaction was between SUV and stage IV disease.SUV seems to have independent prognostic value in stage I-III NSCLC, for squamous cell carcinoma and for adenocarcinoma.
Copyright ©ERS 2015.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26405289     DOI: 10.1183/13993003.00099-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

Review 1.  Advances in Imaging and Automated Quantification of Malignant Pulmonary Diseases: A State-of-the-Art Review.

Authors:  Bruno Hochhegger; Matheus Zanon; Stephan Altmayer; Gabriel S Pacini; Fernanda Balbinot; Martina Z Francisco; Ruhana Dalla Costa; Guilherme Watte; Marcel Koenigkam Santos; Marcelo C Barros; Diana Penha; Klaus Irion; Edson Marchiori
Journal:  Lung       Date:  2018-10-09       Impact factor: 2.584

2.  Primary Sarcomatoid Carcinoma of the Lung: Radiometabolic ((18)F-FDG PET/CT) Findings and Correlation with Clinico-Pathological and Survival Results.

Authors:  Cristian Rapicetta; Filippo Lococo; Alessandro Stefani; Giulio Rossi; Tommaso Ricchetti; Angelina Filice; Antonella Franceschetto; Giorgio Treglia; Massimiliano Paci
Journal:  Lung       Date:  2016-06-14       Impact factor: 2.584

3.  18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.

Authors:  Sara Carvalho; Ralph T H Leijenaar; Esther G C Troost; Janna E van Timmeren; Cary Oberije; Wouter van Elmpt; Lioe-Fee de Geus-Oei; Johan Bussink; Philippe Lambin
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

4.  The assessment of correlation and prognosis among 18F-FDG uptake parameters, Glut1, pStat1 and pStat3 in surgically resected non-small cell lung cancer patients.

Authors:  Hayato Kaida; Koichi Azuma; Akihiko Kawahara; Eiji Sadashima; Satoshi Hattori; Shinzo Takamori; Jun Akiba; Kiminori Fujimoto; Axel Rominger; Takamichi Murakami; Kazunari Ishii; Masatoshi Ishibashi
Journal:  Oncotarget       Date:  2018-08-10

5.  Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics.

Authors:  Janna E van Timmeren; Sara Carvalho; Ralph T H Leijenaar; Esther G C Troost; Wouter van Elmpt; Dirk de Ruysscher; Jean-Pierre Muratet; Fabrice Denis; Tanja Schimek-Jasch; Ursula Nestle; Arthur Jochems; Henry C Woodruff; Cary Oberije; Philippe Lambin
Journal:  PLoS One       Date:  2019-06-03       Impact factor: 3.240

6.  Prognostic impact of maximum standardized uptake value on 18 F-FDG PET/CT imaging of the primary lung lesion on survival in advanced non-small cell lung cancer: A retrospective study.

Authors:  Xiaoling Qiu; Hongge Liang; Wei Zhong; Jing Zhao; Minjiang Chen; Zhaohui Zhu; Yan Xu; Mengzhao Wang
Journal:  Thorac Cancer       Date:  2021-01-29       Impact factor: 3.500

7.  Clinicopathological characteristics and survival in lung signet ring cell carcinoma: a population-based study.

Authors:  Yunting Cai; Yan Xie; Yanli Xiong; Wei Guan; Yu Pu; Dong Wang; Mingfang Xu; Shenglan Meng
Journal:  Bosn J Basic Med Sci       Date:  2021-12-01       Impact factor: 3.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.